Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy-Reference-Cited by-同舟云学术

Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy

Published:2021-11-09 Issue: Volume: Page:
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Bellone Matteo,Bregni Marco,Bronte Vincenzo,Ugel Stefano,Ferrucci Pier Francesco,Di Nicola Massimo,Nisticò Paola,Zuccolotto Gaia,Rosato Antonio,Russo Vincenzo,Sica Antonio,Colombo Mario P.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-021-03104-1.pdf

Reference40 articles.

1. Petitprez F, de Reynies A, Keung EZ et al (2020) B cells are associated with survival and immunotherapy response in sarcoma. Nature 577:556–560. https://doi.org/10.1038/s41586-019-1906-8

2. Roumenina LT, Daugan MV, Noe R et al (2019) Tumor cells hijack macrophage-produced complement C1q to promote tumor growth. Cancer Immunol Res 7:1091–1105. https://doi.org/10.1158/2326-6066.CIR-18-0891

3. Lienart S, Merceron R, Vanderaa C et al (2018) Structural basis of latent TGF-beta1 presentation and activation by GARP on human regulatory T cells. Science 362:952–956. https://doi.org/10.1126/science.aau2909

4. de Streel G, Bertrand C, Chalon N et al (2020) Selective inhibition of TGF-beta1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer. Nat Commun 11:4545. https://doi.org/10.1038/s41467-020-17811-3

5. Kalafati L, Kourtzelis I, Schulte-Schrepping J et al (2020) Innate immune training of granulopoiesis promotes anti-tumor activity. Cell 183(771–85):e12. https://doi.org/10.1016/j.cell.2020.09.058